Skip to main content

Lifecore Biomedical, Inc. De 10-Q for FY2027 Q1

Lifecore Biomedical, Inc. De (LFCR)

10-Q 2026-11-04 For: 2026-09-30
View Original
Added on November 04, 2026

About this 10-Q

Lifecore Biomedical, Inc. De filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2027 Q1).

Lifecore entered a merger agreement with affiliates of Webster Equity Partners on September 27, 2026 as nine-month revenue fell $23.0 million. All 50,187 Series A Preferred Stock shares were tendered for redemption, scheduled for December 28, 2026. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$25.32M
down 18.6% from $31.11M a year earlier
Net loss
$40.08M
compared with a net loss of $9.99M a year earlier
Diluted EPS
-$1.08
compared with -$0.29 a year earlier